Simplex Trading’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-28,828
Closed -$5.18M 7283
2017
Q3
$5.18M Buy
+28,828
New +$4.02M 0.21% 73
2016
Q4
Sell
-6,394
Closed -$314K 7045
2016
Q3
$357K Buy
+6,394
New +$356K 0.02% 679
2015
Q3
Sell
-23
Closed -$1.45K 6657
2015
Q2
$1K Sell
23
-16,021
-100% -$914K ﹤0.01% 4959
2015
Q1
$925K Buy
16,044
+13,954
+668% +$935K 0.11% 176
2014
Q4
$121K Buy
+2,090
New +$88K 0.01% 826

Simplex Trading's KITE Position: Q4 2017 in Review

Simplex Trading sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 28,828 shares — an estimated $5.18M sold.

Simplex Trading first reported a position in KITE in Q4 2014 and held it in 5 quarters. The position peaked at $5.18M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Simplex Trading reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Simplex Trading sold 28,828 Kite Pharma, Inc. shares in Q4 2017, an estimated $5.18M.
  • Simplex Trading first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 5 quarters.
  • Simplex Trading's Kite Pharma, Inc. position peaked at $5.18M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Simplex Trading's 13F filing for Q4 2017, filed 10 Jan 2018.